Skip to main content

Table 1 Patient demographics

From: Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study

Characteristic

Category

n

Age Group

35–40

3

41–45

4

46–50

1

51–55

3

>56

1

Ethnicity

Non-Hispanic

7

Hispanic

4

Other

1

Cell Type

Squamous Cell Carcinoma

7

Adenocarcinoma

3

Lines of Prior Therapy

1

8

2

2

Prior Radiation

Yes

9

No

1

Prior Surgery

Yes

5

No

5

Prior Paclitaxel

Yes

9

No

1

Prior Bevacizumab

Yes

6

No

4